Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azeez Farooki

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
NCCN bone health task force: key recommendationsAzeez Farooki
Frontiers in Endocrinology|June 2, 2023
Refractory hypercalcemia of malignancy: a problem with many potential rootsAzeez Farooki
Annals of the New York Academy of Sciences|October 16, 2010
Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the boneSerge Cremers, Azeez Farooki
Postgraduate Medicine|November 30, 2016
Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitusThomas C Blevins, Azeez Farooki
Integrative Cancer Therapies|January 25, 2022
Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated HyperglycemiaMarcus D Goncalves, Azeez Farooki
British Journal of Clinical Pharmacology|December 12, 2018
Antiresorptive agents' bone-protective and adjuvant effects in postmenopausal women with early breast cancerTariq Chukir, Yi Liu, Azeez Farooki
Endocrine-Related Cancer|January 31, 2014
Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapiesJosé O Alemán, Azeez Farooki, Monica Girotra
Therapeutic Advances in Endocrinology and Metabolism|September 4, 2025
Bone health in cancer: perspective on the use of osteoanabolic agentsTariq Chukir, Hanna Taipaleenmäeki, Melody Cheung, et al.
Journal of Investigative Medicine High Impact Case Reports|April 24, 2019
Pituitary as a Source of HCG: Residual Levels After Bilateral Testicular Tumor RemovalRichard Santen, Farhad Hasan, Katie Thoren, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Skeletal-related events due to bone metastases from differentiated thyroid cancerAzeez Farooki, Vivien Leung, Hernan Tala, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
NCCN bone health task force: key recommendationsAzeez Farooki
Frontiers in Endocrinology|June 2, 2023
Refractory hypercalcemia of malignancy: a problem with many potential rootsAzeez Farooki
Annals of the New York Academy of Sciences|October 16, 2010
Biochemical markers of bone turnover in osteonecrosis of the jaw in patients with osteoporosis and advanced cancer involving the boneSerge Cremers, Azeez Farooki
Postgraduate Medicine|November 30, 2016
Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitusThomas C Blevins, Azeez Farooki
Integrative Cancer Therapies|January 25, 2022
Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated HyperglycemiaMarcus D Goncalves, Azeez Farooki
British Journal of Clinical Pharmacology|December 12, 2018
Antiresorptive agents' bone-protective and adjuvant effects in postmenopausal women with early breast cancerTariq Chukir, Yi Liu, Azeez Farooki
Endocrine-Related Cancer|January 31, 2014
Effects of tyrosine kinase inhibition on bone metabolism: untargeted consequences of targeted therapiesJosé O Alemán, Azeez Farooki, Monica Girotra
Therapeutic Advances in Endocrinology and Metabolism|September 4, 2025
Bone health in cancer: perspective on the use of osteoanabolic agentsTariq Chukir, Hanna Taipaleenmäeki, Melody Cheung, et al.
Journal of Investigative Medicine High Impact Case Reports|April 24, 2019
Pituitary as a Source of HCG: Residual Levels After Bilateral Testicular Tumor RemovalRichard Santen, Farhad Hasan, Katie Thoren, et al.
The Journal of Clinical Endocrinology and Metabolism|May 9, 2012
Skeletal-related events due to bone metastases from differentiated thyroid cancerAzeez Farooki, Vivien Leung, Hernan Tala, et al.
Pageof 5